Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO).
Pinter A, Costanzo A, Khattri S, Smith SD, Carrascosa JM, Tada Y, Riedl E, Reich A, Brnabic A, Haustrup N, Lampropoulou A, Lipkovich I, Kadziola Z, Paul C, Schuster C. Pinter A, et al. Among authors: lipkovich i. Dermatol Ther (Heidelb). 2024 May 30. doi: 10.1007/s13555-024-01105-3. Online ahead of print. Dermatol Ther (Heidelb). 2024. PMID: 38814435 No abstract available.
Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
Brnabic AJM, Curtis SE, Johnston JA, Lo A, Zagar AJ, Lipkovich I, Kadziola Z, Murray MH, Ryan T. Brnabic AJM, et al. Among authors: lipkovich i. PLoS One. 2024 Mar 22;19(3):e0300708. doi: 10.1371/journal.pone.0300708. eCollection 2024. PLoS One. 2024. PMID: 38517926 Free PMC article.
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO).
Pinter A, Costanzo A, Khattri S, Smith SD, Carrascosa JM, Tada Y, Riedl E, Reich A, Brnabic A, Haustrup N, Lampropoulou A, Lipkovich I, Kadziola Z, Paul C, Schuster C. Pinter A, et al. Among authors: lipkovich i. Dermatol Ther (Heidelb). 2023 Dec 19. doi: 10.1007/s13555-023-01086-9. Online ahead of print. Dermatol Ther (Heidelb). 2023. PMID: 38113010
Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study.
Nowell WB, Curtis JR, Zhao H, Xie F, Stradford L, Curtis D, Gavigan K, Boles J, Clinton C, Lipkovich I, Venkatachalam S, Calvin A, Hayes VS. Nowell WB, et al. Among authors: lipkovich i. JMIR Hum Factors. 2023 Nov 7;10:e44034. doi: 10.2196/44034. JMIR Hum Factors. 2023. PMID: 37934559 Free PMC article.
Activation, physical activity, and outcomes among individuals with T2D.
Nair R, Meadows E, Sheer R, Lipkovich I, Poon JL, Zhao Z, Benneyworth B, Pasquale M. Nair R, et al. Among authors: lipkovich i. Am J Manag Care. 2022 Aug;28(8):374-380. doi: 10.37765/ajmc.2022.89197. Am J Manag Care. 2022. PMID: 35981122 Free article.
71 results